Eisai launches epilepsy drug in UK
Eisai has launched its first-in-class epilepsy drug Fycompa in the UK, prior to a roll-out in EU member states including Germany.
India has 10-15 million epilepsy patients but the good news is that the problem can be controlled in 80 percent cases, experts said here today.